Oura's recent confidential IPO filing and August 2026 reports of a potential September debut seeking up to $3 billion at a valuation above $16 billion have centered trader attention on revenue scaling and the shift toward recurring subscription revenue from health data insights. The company reported roughly $500 million in 2024 revenue, about $1 billion in 2025, and targets near $2 billion in 2026, supported by more than 5.5 million rings sold and five million paid members. This growth from the prior $11 billion private valuation implies forward multiples that could support mid-teens to $20 billion-plus outcomes, yet secondary share sales, competition from Samsung and Whoop, and broader 2026 IPO market dynamics create balanced uncertainty reflected in the closely matched market-implied odds across brackets.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated<$7.5B 15%
$20B+ 15%
$15B–$17.5B 14%
$7.5B–$10B 14%
$261,962 Vol.
$261,962 Vol.
<$7.5B
15%
$7.5B–$10B
14%
$10B–$12.5B
13%
$12.5B–$15B
11%
$15B–$17.5B
14%
$17.5B–$20B
13%
$20B+
15%
No IPO before January 2027
3%
<$7.5B 15%
$20B+ 15%
$15B–$17.5B 14%
$7.5B–$10B 14%
$261,962 Vol.
$261,962 Vol.
<$7.5B
15%
$7.5B–$10B
14%
$10B–$12.5B
13%
$12.5B–$15B
11%
$15B–$17.5B
14%
$17.5B–$20B
13%
$20B+
15%
No IPO before January 2027
3%
If no IPO occurs by December 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before January 2027".
Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the number of shares outstanding multiplied by the closing share price on the first trading day.
If the relevant value falls exactly between two brackets, then this market will resolve to the higher range bracket.
Resolution will be based on the primary exchange’s official listing page. In the event that the relevant figure is not displayed, another reliable source will be used.
In the event of an interruption in the course of the normal trading session on Oura’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that as the first day of trading for purposes of this market.
Market Opened: May 26, 2026, 12:28 PM ET
Resolver
0x69c47De9D...If no IPO occurs by December 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before January 2027".
Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the number of shares outstanding multiplied by the closing share price on the first trading day.
If the relevant value falls exactly between two brackets, then this market will resolve to the higher range bracket.
Resolution will be based on the primary exchange’s official listing page. In the event that the relevant figure is not displayed, another reliable source will be used.
In the event of an interruption in the course of the normal trading session on Oura’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that as the first day of trading for purposes of this market.
Resolver
0x69c47De9D...Oura's recent confidential IPO filing and August 2026 reports of a potential September debut seeking up to $3 billion at a valuation above $16 billion have centered trader attention on revenue scaling and the shift toward recurring subscription revenue from health data insights. The company reported roughly $500 million in 2024 revenue, about $1 billion in 2025, and targets near $2 billion in 2026, supported by more than 5.5 million rings sold and five million paid members. This growth from the prior $11 billion private valuation implies forward multiples that could support mid-teens to $20 billion-plus outcomes, yet secondary share sales, competition from Samsung and Whoop, and broader 2026 IPO market dynamics create balanced uncertainty reflected in the closely matched market-implied odds across brackets.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated


Beware of external links.
Beware of external links.
Frequently Asked Questions